Clinical Trial Update: Paricalcitol Injection Phase II Trial [Phase 2]

View source ↗

Summary

Phase II trial of paricalcitol injection for chronic kidney disease has completed. The update provides results from this mid-stage study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Paricalcitol Injection (paricalcitol)

Snippet

Sponsor: Abbott | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED